Advertisement
Australia markets closed
  • ALL ORDS

    8,120.20
    -11.90 (-0.15%)
     
  • AUD/USD

    0.6670
    -0.0001 (-0.02%)
     
  • ASX 200

    7,851.70
    -12.00 (-0.15%)
     
  • OIL

    78.73
    -1.07 (-1.34%)
     
  • GOLD

    2,421.30
    -17.20 (-0.71%)
     
  • Bitcoin AUD

    106,502.84
    +5,937.96 (+5.90%)
     
  • CMC Crypto 200

    1,536.00
    +47.46 (+3.19%)
     

AYR Wellness to Hold First Quarter 2024 Conference Call on May 15 at 8:30 a.m. ET

Ayr Wellness Inc.
Ayr Wellness Inc.

MIAMI, April 11, 2024 (GLOBE NEWSWIRE) -- AYR Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), will hold a conference call on Wednesday, May 15, 2024, at 8:30 a.m. ET to discuss its results for the first quarter ended March 31, 2024.

AYR President & CEO David Goubert and CFO Brad Asher will host the conference call, followed by a question-and-answer period. The Company will provide its financial results in a press release prior to the call.

Date: Wednesday, May 15, 2024
Time: 8:30 a.m. ET
Toll-free dial-in number: (844) 763-8274
International dial-in number: (647) 484-8814
Conference ID: 10023271
Webcast: https://services.choruscall.ca/links/ayrwellness2024q1.html

ADVERTISEMENT

A telephonic replay of the conference call will also be available for one month until end of day Saturday, June 15, 2024.

Toll-free replay number: (855) 669-9658
International replay number: (412) 317-0088
Replay ID: 0806

Please dial into the conference call 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact the company’s investor relations team at ir@ayrwellness.com.

About AYR Wellness Inc.

AYR Wellness is a vertically integrated, U.S. multi-state cannabis business. The Company operates simultaneously as a retailer with 90+ licensed dispensaries and a house of cannabis CPG brands.

AYR is committed to delivering high-quality cannabis products to its patients and customers while acting as a Force for Good for its team members and the communities that the Company serves. For more information, please visit www.ayrwellness.com.

Company Contact:

Jon DeCourcey
Head of Investor Relations
T: (786) 885-0397
Email: ir@ayrwellness.com

Media Contact:

Robert Vanisko
VP, Public Engagement
T: (786) 885-0397
Email: comms@ayrwellness.com

Investor Relations Contact:

Sean Mansouri, CFA
Elevate IR
T: (786) 885-0397
Email: ir@ayrwellness.com